Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions

Genetics and Molecular Research

Volumn 16, Issue 3, 2017, Pages

  Chagas, B S ^a   Gurgel, A P A D ^b   Paiva Junior S S L ^c   Lima, R C P ^a   Cordeiro, M N ^a   Moura, R R ^a,d   Coelho, A V C ^a   Nascimento, K C G ^a   Silva Neto, J C ^a   Crovella, S ^a,d,e   Freitas, A C ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Cervical cancer; Contraceptive; Glutathione S transferase; Human papillomavirus

Indexed keywords

EID: 85028327950     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/gmr16039742     Document Type: Article

References (39)

1. Baldez da Silva MFPT, Chagas BS, Guimarães V, Katz LM, et al. (2009). HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. Genet. Mol. Res. 8: 1437-1443. https://doi.org/10.4238/vol8-4gmr677
2. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, et al. (2002). The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55: 244-265. https://doi.org/10.1136/jcp.55.4.244
3. Bromberg-White JL and Meyers C (2002). The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J. Virol. 76: 9702-9715. https://doi.org/10.1128/JVI.76.19.9702-9715.2002
4. Butz K and Hoppe-Seyler F (1993). Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol. 67: 6476-6486.
5. Chagas BS, Comar M, Gurgel APAD, Paiva S, et al. (2015). Association study between cervical lesions and single or multiple vaccine-target and non-vaccine target Human papillomavirus (HPV) types in women from Northeastern Brazil. PLoS One 10: e0132570. https://doi.org/10.1371/journal.pone.0132570
6. Chen YH, Huang LH and Chen TM (1996). Differential effects of progestins and estrogens on long control regions of human papillomavirus types 16 and 18. Biochem. Biophys. Res. Commun. 224: 651-659. https://doi.org/10.1006/bbrc.1996.1080
7. Comar M, Iannacone MR, Casalicchio G, McKay-Chopin S, et al. (2012). Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance. J. Clin. Microbiol. 50: 4041-4046. https://doi. org/10.1128/JCM.02105-12
8. De Luca A, Federici L, De Canio M, Stella L, et al. (2012). New insights into the mechanism of JNK1 inhibition by glutathione transferase P1-1. Biochemistry 51: 7304-7312. https://doi.org/10.1021/bi300559m
9. Efird JT, Toland AE, Lea CS and Phillips CJ (2011). The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clin. Med. Insights Oncol. 5: 55-75. https://doi. org/10.4137/CMO.S6905
10. Elhoseiny S, El-Wakil M, Fawzy M and Rahman AA (2014). GSTP1 (Ile105Val) Gene Polymorphism: Risk and Treatment Response in Chronic Myeloid Leukemia. J. Cancer Ther. 5: 1. https://doi.org/10.4236/jct.2014.51001
11. Fernandes JV, Meissner RdeV, Carvalho MG, Fernandes TA, et al. (2011). Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil. Mol. Med. Rep. 4: 1321-1326.
12. de Freitas AC, Gurgel APAD, Chagas BS, Coimbra EC, et al. (2012). Susceptibility to cervical cancer: an overview. Gynecol. Oncol. 126: 304-311. https://doi.org/10.1016/j.ygyno.2012.03.047
13. González JR, Armengol L, Guinó E, Sol X, et al. (2007). SNPassoc: SNPs-based whole genome association studies. R package version 1.9-2. http://CRAN.R-project.org/package=SNPassoc.
14. Hannaford PC, Selvaraj S, Elliott AM, Angus V, et al. (2007). Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner’s oral contraception study. BMJ 335: 651. https://doi.org/10.1136/bmj.39289.649410.55
15. Hayes JD, Flanagan JU, Jowsey IR, Hayes J, et al. (2005). Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45: 51-88. https://doi.org/10.1146/annurev.pharmtox.45.120403.095857
16. Hengstler JG, Arand M, Herrero ME and Oesch F (1998). Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res. 154: 47-85. https://doi.org/10.1007/978-3-642-46870-4_4
17. Henningson MC, Hietala M, Bågeman E, Olsson H, et al. (2010). Interactions between oral contraceptive status and GSTM1 and GSTT1 deletions on insulin-like growth factor-1 (IGF-1) plasma levels in young healthy women. Growth Horm. IGF Res. 20: 432-437. https://doi.org/10.1016/j.ghir.2010.10.003
18. Jemal A, Bray F, Center MM, Ferlay J, et al. (2011). Global cancer statistics. CA Cancer J. Clin. 61: 69-90. https://doi. org/10.3322/caac.20107
19. Jernström H, Loman N, Johannsson OT, Borg A, et al. (2005). Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur. J. Cancer 41: 2312-2320. https://doi.org/10.1016/j.ejca.2005.03.035
20. Joseph T, Chacko P, Wesley R, Jayaprakash PG, et al. (2006). Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol. Oncol. 101: 411-417. https://doi.org/10.1016/j.ygyno.2005.10.033
21. Josephy PD (2010). Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum. Genomics Proteomics 2010: 876940. https://doi.org/10.4061/2010/876940
22. Kiran B, Karkucak M, Ozan H, Yakut T, et al. (2010). GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J. Gynecol. Oncol. 21: 169-173. https://doi.org/10.3802/jgo.2010.21.3.169
23. Kou X, Chen N, Feng Z, Luo L, et al. (2013). GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling. Oncol. Lett. 5: 1053-1057.
24. Kumar MM, Davuluri S, Poojar S, Mukherjee G, et al. (2016). Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study. Tumour Biol. 37: 4409-4420. https://doi.org/10.1007/s13277-015-4257-6
25. La Vecchia C and Boccia S (2014). Oral contraceptives, human papillomavirus and cervical cancer. Eur. J. Cancer Prev. 23: 110-112. https://doi.org/10.1097/CEJ.0000000000000000
26. La Vecchia C, Altieri A, Franceschi S and Tavani A (2001). Oral contraceptives and cancer: an update. Drug Saf. 24: 741-754. https://doi.org/10.2165/00002018-200124100-00003
27. Mannervik B, Awasthi YC, Board PG, Hayes JD, et al. (1992). Nomenclature for human glutathione transferases. Biochem. J. 282: 305-306. https://doi.org/10.1042/bj2820305
28. Moore EE, Wark JD, Hopper JL, Erbas B, et al.; CeCaGeEn Study Group (2012). The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies. Twin Res. Hum. Genet. 15: 79-86. https://doi. org/10.1375/twin.15.1.79
29. Nakajima T and Aoyama T (2000). Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Ind. Health 38: 143-152. https://doi.org/10.2486/indhealth.38.143
30. Rodríguez M, Mejia F, Lecourtois M, Domínguez V, et al. (2014). Influence of GSTT1, GSTM1 and GSTP1 Polymorphisms on the Development of Breast Cancer. J. Cancer Ther. 5: 552-559. https://doi.org/10.4236/jct.2014.56063
31. Sheweita SA (2000). Drug-metabolizing enzymes: mechanisms and functions. Curr. Drug Metab. 1: 107-132. https://doi. org/10.2174/1389200003339117
32. Singh H, Sachan R, Devi S, Pandey SN, et al. (2008). Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population. Am. J. Obstet. Gynecol. 198: 303.e1-303.e6. https://doi.org/10.1016/j.ajog.2007.09.046
33. Strange RC, Spiteri MA, Ramachandran S and Fryer AA (2001). Glutathione-S-transferase family of enzymes. Mutat. Res. 482: 21-26. https://doi.org/10.1016/S0027-5107(01)00206-8
34. Townsend D and Tew K (2003). Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am. J. Pharmacogenomics 3: 157-172. https://doi.org/10.2165/00129785-200303030-00002
35. Urban M, Banks E, Egger S, Canfell K, et al. (2012). Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med. 9: e1001182. https://doi.org/10.1371/journal.pmed.1001182
36. Wajid S, Naqvi SH, Juneja A, Bharadwaj M, et al. (2007). Allelic variations in CYP2D6 gene and susceptibility to cervical cancer. Drug Metab. Lett. 1: 276-280. https://doi.org/10.2174/187231207783221367
37. Weyn C, Vanderwinden JM, Rasschaert J, Englert Y, et al. (2011). Regulation of human papillomavirus type 16 early gene expression in trophoblastic and cervical cells. Virology 412: 146-155. https://doi.org/10.1016/j.virol.2010.12.056
38. Ylitalo N, Sørensen P, Josefsson A, Frisch M, et al. (1999). Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int. J. Cancer 81: 357-365. https://doi.org/10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.0.CO;2-1
39. Zhao X, Fan Y, Shen J, Wu Y, et al. (2006). Human glutathione S-transferase P1 suppresses MEKK1-mediated apoptosis by regulating MEKK1 kinase activity in HEK293 cells. Mol. Cells 21: 395-400.